ANCAPROAnxiety Assessment in Localized Prostate Cancer Patients Under Active Surveillance and Their Partners

Prostate cancer is a common health issue among men in France, and it's one of the leading causes of cancer-related deaths. When prostate cancer is at a low risk level, one of the management options is 'active surveillance'. This approach aims to postpone or even avoid more drastic treatments like surgery or radiotherapy, which can lead to side effects such as urinary incontinence, erectile dysfunction, or radiation-induced cystitis. Active surveillance involves regular check-ups to monitor the cancer, including blood tests, MRI scans, and prostate biopsies. However, there's limited understanding of how this process affects patients and their partners emotionally, particularly in terms of anxiety. This study aims to fill this gap, hoping to provide better psychological support for those involved. During the study, participants will complete a questionnaire known as the 'Memorial Anxiety Scale for Prostate Cancer'. This questionnaire has been translated into French and its accuracy has been confirmed. The total score from this questionnaire helps identify individuals who may be experiencing anxiety. A score above 27 out of 54 indicates the presence of anxiety symptoms. The primary goal of this study is to understand how common anxiety symptoms are among patients undergoing active surveillance for prostate cancer.